JESSICA SHAMAS: Open Payments
NPI 1144067885 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 14 payments from 8 companies in 2025. Trend: 2023 $19 · 2024 $102 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $76 |
| Astellas Pharma US Inc | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: General - Embolics, Veozah, AIRSUPRA, CAPLYTA, GEMTESA, XIFAXAN, Kerendia, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
